AhlersN., HuntN., JustU., LakerC., OstertagW., NowockJ.1994. Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression. J. Virol., 68:7235–7243.
2.
BaumC., Hegewisch-BeckerS., EckertH.G., StockingC., OstertagW.1995. Novel retroviral vectors for efficient expression of the multidrug-resistance (mdr-1) gene in early hemopoietic cells. J. Virol., 69:7541–7547.
3.
Beck-EngeserG., StockingC., JustU., AlbrittonL., DexterM., SpooncerE., OstertagW.1991. Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. Hum. Gene Ther., 2:61–70.
ChallitaP.M., SkeltonD., El-KhoueiryA., YuX.J., WeinbergK., KohnD.B.1995. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol., 69:748–755.
6.
DubeS.K., OstertagW.1991. AZT before AIDS. Nature, 352:114.
7.
FehseB., AyukF.A., KrögerN., FangL., KühlckeK., HeinzelmannM., ZabelinaT., FauserA.A., ZanderA.R.2004. Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells. Blood, 104:3408–3409.
8.
FranzT., HilbergF., SeligerB., StockingC., OstertagW.1986. Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc. Natl. Acad. Sci. U.S.A., 83:3292–3296.
9.
GasparH.B., BjorkegrenE., ParsleyK., GilmourK.C., KingD., SinclairJ., ZhangF., GiannakopoulosA., AdamsS., FairbanksL.D., GasparJ., HendersonL., Xu-BayfordJ.H., DaviesE.G., VeysP.A., KinnonC., ThrasherA.J.2006. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther., 14:505–513.
10.
GrezM., AkgunE., HilbergF., OstertagW.1990. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A., 87:9202–9206.
11.
HildingerM., AbelK.L., OstertagW., BaumC.1999. Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J. Virol., 73:4083–4089.
12.
HildingerM., DittmarM.T., Schult-DietrichP., FehseB., SchnierleB.S., ThalerS., StieglerG., WelkerR., von LaerD.2001. Membrane-anchored peptide inhibits human immunodeficiency virus entry. J. Virol., 75:3038–3042.
13.
ItohK., FrielJ., KlugeN., KinaT., Kondo-TakaoriA., KawamataS., UchiyamaT., OstertagW.1996. A novel hematopoietic multilineage clone, Myl-D-7, is stromal cell-dependent and supported by an alternative mechanism(s) independent of stem cell factor/c-kit interaction. Blood, 87:3218–3228.
14.
JustU., StockingC., SpooncerE., DexterT.M., OstertagW.1991. Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation. Cell, 64:1163–1173.
15.
KollekR., StockingC., Smadja-JoffeF., OstertagW.1984. Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants. J. Virol., 50:717–724.
MileticH., BrunsM., TsiakasK., VogtB., RezaiR., BaumC., KuhlkeK., CossetF.L., OstertagW., LotherH., von LaerD.1999. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J. Virol., 73:6114–6116.
18.
NibbsR.J., ItohK., OstertagW., HarrisonP.R.1993. Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53. Mol. Cell. Biol., 13:5582–5592.
19.
OstertagW., RoeslerG., KriegC.J., KindJ., ColeT., CrozierT., GaedickeG., SteinheiderG., KlugeN., DubeS.1974. Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus. Proc. Natl. Acad. Sci. U.S.A., 71:4980–4985.
20.
OttM.G., SchmidtM., SchwarzwaelderK., SteinS., SilerU., KoehlU., GlimmH., KuhlckeK., SchilzA., KunkelH., NaundorfS., BrinkmannA., DeichmannA., FischerM., BallC., PilzI., DunbarC., DuY., JenkinsN.A., CopelandN.G., LuthiU., HassanM., ThrasherA.J., HoelzerD., von KalleC., SegerR., GrezM.2006. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med., 12:401–409.
StockingC., KollekR., BergholzU., OstertagW.1985. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc. Natl. Acad. Sci. U.S.A., 82:5746–5750.
23.
StockingC., LoligerC., KawaiM., SuciuS., GoughN., OstertagW.1988. Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants. Cell, 53:869–879.
24.
StockingC., BergholzU., FrielJ., KlinglerK., WagenerT., StarkeC., KitamuraT., MiyajimaA., OstertagW.1993. Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line. Growth Factors, 8:197–209.
25.
van LunzenJ., GlaunsingerT., StahmerI., von BaehrV., BaumC., SchilzA., KuehlckeK., NaundorfS., MartiniusH., HermannF., GiroglouT., NewrzelaS., MüllerI., BrauerF., BrandenburgG., AlexandrovA., von LaerD.2007. Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol. Ther., 15:1024–1033.
